LONDON, November 30, 2016 /PRNewswire/ --
Exploring
solutions to the mismatch in progress and delivery
in cancer care
Tweet your questions
ahead of the event
via @EconomistEvents
#WaronCancer
The Economist Events' second annual War on Cancer 2016 will
bring together over 150 global leaders in oncology to explore
solutions to the mismatch in progress and delivery in cancer care
across Europe. The forum will
discuss innovative approaches to cancer prevention and treatment,
solutions to overcome shortcomings in delivery and examples of best
practices and opportunities for cross-sectoral collaboration.
The forum will be held on Tuesday,
December 6th 2016 at the Marriott Grosvenor
Square, London,
from 8:00am to 5:40pm.
Mary-Jane Elliott,
Managing Partner at Consilium
Strategic Communications, the Official
PR Agency for The Economist
Events' War on Cancer forum,
commented: "Healthcare systems around
the world are facing a range of challenges, many of
which have the potential to directly impact how cancer will be
treated in the future. This forum will bring
together leading oncologists and other key
stakeholders to discuss how we can ensure
health systems remain sustainable in order to deliver promising
new technologies and treatments in the fight against
cancer. Consilium is very proud to support the
event again for this, its second year.
We are looking forward to the forum, the panels and
the lively discussions it will provoke."
Innovative approaches to cancer treatment, prevention and care
are emerging at an unprecedented rate. However, the policies and
systems in place to deliver these advancements to people are
lagging behind. Currently in the UK to get a new medicine from the
research lab to patients it takes an average of 10 years and £1
billion. Whether we are fighting cancer with novel therapies or
adopting the latest preventative guidance, we must ensure that our
systems are up to the task of delivering progress. How do we scale
the knowledge and capability in oncology that we already have and
prepare for what's coming?
Key speakers at the summit
include:
- Matti Aapro, Board
Member, European Cancer Organisation
- Cary Adams, Chief
Executive Officer, Union for International Cancer Control
- Tit Albreht, Coordinator, Cancer Control Joint
Action (CanCon); Head, National Institute of Public Health of
Slovenia
- Kathi Apostolidis,
Vice-president, European Cancer Patient Coalition (ECPC);
President of Executive Committee, Hellenic Cancer Federation
- ELL.O.K
- Frauke Becker,
Research Associate, Institute of Health and Society,
Newcastle University
- John Bell, Regius
Professor of Medicine, University of
Oxford; Chairman, Office for Strategic Coordination
of Health Research (OSCHR)
- Jurgi Camblong, Chief Executive Officer and
Co-founder, Sophia Genetics
- Josep
Figueras, Director, European Observatory on
Health Systems and Policies; Head, World Health Organization
European Centre on Health Policy
- George Freeman, Member
of Parliament for Mid Norfolk and Chair, Prime
Minister's Policy Board
- David
Khayat, Head of the Department of
Oncology, Pitié-Salpêtrière Hospital and Professor of
Oncology, University Pierre and Marie
Curie
- Bryony Kimmings, Creator of the musical
'A Pacifist's Guide to the War on
Cancer'
- Jane Maher, Chief
Medical Officer, Macmillan Cancer Support
- Lydia Makaroff,
Director, European Cancer Patient Coalition
- Mahiben Maruthappu, Co-founder, NHS Innovation
Accelerator
- Maya Martinez -
Davis, Senior Vice-president, Global Head of Oncology
Franchise, Merck KGaA
- Vivek
Muthu, Chair, Economist Intelligence Unit
Healthcare
- Luca
Pani, CHMP-SAWP, Member European Medicines
Agency (EMA); Department of Psychiatry and Behavioral Sciences,
University of Miami
- Annie Pannelay, Healthcare Principal, Economist
Intelligence Unit
- Terje
Peetso, Policy Officer, Directorate-General
Communications Networks, Content and Technology, European
Commission
- Andreas Penk, Regional President Oncology,
International Developed Markets, Pfizer
- Jem Rashbass, National Director for Disease
Registration, Public Health England
- Gunnar
Saeter, Professor and Head of Institute,
Institute for Cancer Research - Olso University Hospital
- Katherine Smith,
Reader- Global Public Health Unit, University of Edinburgh
- Zhen Su,
Vice-president, US Oncology Medical Affairs, EMD Serono
- Richard Sullivan,
Professor of Cancer and Global Health, King's
College London; Director, Institute of Cancer Policy
- Frans van
Houten, Chief Executive and Chairman,
Philips
- Paul
Workman, Chief Executive Officer and President,
The Institute of Cancer Research London; Harrap Professor of
Pharmacology and Therapeutics
For more information and to view the full programme please
visit:
http://www.economist.com/events-conferences/emea/war-cancer#ec-event-overview
Follow the War on Cancer summit via @EconomistEvents
#WaronCancer on Twitter to get the latest updates, submit your
questions, and join in with discussions on the day.
Want more from The Economist Events?
Join us on Twitter: @EconomistEvents
About The Economist Events
The Economist Events' philosophy is to tackle issues with a
forward-looking, uniquely global perspective. We aim to create
events for the intellectually curious: people who enjoy ideas and
who are passionate about the issues that define our world.
Attend our events:
http://www.economist.com/events-conferences/emea
Founding sponsor: Bristol-Myers Squibb
Bristol-Myers Squibb is a global
biopharmaceutical company whose mission is to discover, develop and
deliver innovative medicines that help patients prevail over
serious diseases. We are committed to changing survival
expectations in hard-to-treat cancers and the way patients live
with cancer through our pioneering, comprehensive Immuno-Oncology
portfolio and clinical program as well as research collaborations
with academia and biotech companies.
Founding sponsor: Merck
Merck discovers, develops, manufactures and markets prescription
medicines of both chemical and biological origin in specialist
indications. We have an enduring commitment to deliver novel
therapies in our core focus areas including oncology and
immuno-oncology; supporting patients with cancer. Merck has a
robust pipeline of potential therapies in oncology, immuno-oncology
and immunology.
Gold sponsor: Pfizer Oncology
Pfizer Oncology is focused on helping to redefine life with
cancer. By maximizing our internal scientific resources and
collaborating with other companies, government and academic
institutions, we bring together the brightest and most enterprising
minds to take on the toughest cancers, helping speed breakthrough
treatments to patients around the world.
Silver Sponsor: Novartis
Novartis Oncology is a global leader in providing a broad range
of innovative therapies to help improve the lives of cancer
patients.
Silver Sponsor: Varian Medical Systems
Global manufacturer of medical devices and software for treating
cancer with radiotherapy, radiosurgery, proton therapy and
brachytherapy.
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in
providing trusted, healthcare-focused strategic IR and financial PR
counsel to corporations, Boards, senior decision makers and
executives. From offices in Europe
and USA, Consilium Strategic
Communications' senior team provides cross-border comprehensive
financial and corporate healthcare communications advice to some of
the world's most prominent corporations around-the-clock. For more
information, please visit our website at
http://www.consilium-comms.com
Press enquiries
For further information on event registration or to request
interviews with any of the speakers at War on Cancer 2016
conference, please contact Consilium Strategic Communications,
Official Press Office for The Economist Healthcare Events:
Lindsey Neville
Email: waroncancer2016@consilium-comms.com
Tel: +44 (0)20-3709-5700
For general queries or further information about the event
please call +44(0)207-576-8118 or e-mail
emeaevents@economist.com